Clinical Trial Update: Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

View source ↗

Summary

A post-marketing study to assess the safety and effectiveness of oral atogepant in Korean adults for the prevention of chronic or episodic migraine; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Episodic Migraine
• Migraine

Drugs mentioned

• Qulipta (atogepant)

Snippet

Sponsor: AbbVie | Conditions: Chronic Migraine, Episodic Migraine | Status: RECRUITING